$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Inhibition of 5-lipoxygenase products 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07D-403/30
  • C07D-233/66
  • C07D-401/00
  • C07D-405/00
출원번호 US-0856927 (1986-04-28)
발명자 / 주소
  • Bender Paul E. (Cherry Hill NJ) Griswold Don E. (North Wales PA) Hanna Nabil (Berwyn PA) Sarau Henry M. (Hatfield PA)
출원인 / 주소
  • SmithKline Beckman Corporation (Philadelphia PA 02)
인용정보 피인용 횟수 : 94  인용 특허 : 9

초록

Novel compounds, compositions and pharmaceutical a method of inhibiting the 5-lipoxygenase pathway in an animal in need thereof which comprising administering an effective, 5-lipoxygenase pathway inhibiting amount of a 4,5-diaryl-2(substituted)-imidazole or a pharmaceutically acceptable salt thereof

대표청구항

A compound of the formula [Figure] wherein: X1 is NHCN or NH2; R1 and R are independently selected from 4-pyridyl or monosubstituted phenyl wherein said substituent is selected from halo or C1-4 alkoxy; and Y1 is H or CN provided that when X1 is NH2, Y1 is CN when X1 is NHCN, Y1 is H; or a pharmaceu

이 특허에 인용된 특허 (9)

  1. Ferrini Pier G. (Binningen CHX) Gschke Richard (Bottmingen CHX), 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same.
  2. Cherkofsky Saul C. (Wilmington DE) Sharpe Thomas R. (Fort Salonga NY), Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfon.
  3. Cherkofsky Saul C. (Wilmington DE) Sharpe Thomas R. (Fort Salonga NY), Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones.
  4. Cherkofsky Saul C. (Wilmington DE), Antiinflammatory 4,5-diaryl-2-nitroimidazoles.
  5. Cherkofsky Saul C. (Wilmington DE) Sharpe Thomas R. (Wilmington DE), Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones.
  6. Buchel Karl Heinz (Wuppertal DT), Chlorinated imidazole derivatives and a process for preparing them.
  7. Fitzi Konrad (Neuallschwil CH), Imidazole derivatives in the treatment of pain.
  8. Ferrini Pier G. (Binningen CHX) Gschke Richard (Bottmingen CHX), Mercaptoimidazole derivatives.
  9. Bender Paul E. (Cherry Hill NJ) Lantos Ivan (Blackwood NJ), Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles.

이 특허를 인용한 특허 (94)

  1. Adams,Jerry L.; Boehm,Jeffrey C.; Taggart,John J.; Hall,Ralph F., 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases.
  2. Adams, Jerry L.; Boehm, Jeffrey C.; Hall, Ralph; Jin, Qi; Kasparec, Jiri; Silva, Domingos J.; Taggart, John J., 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy.
  3. Dannhardt,Gerd; Hahn,Linda, 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors.
  4. Adams,Jerry L.; Bower,Michael J.; Boehm,Jeffrey C.; Griswold,Don Edgar; Underwood,David C., 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors.
  5. Adams, Jerry L.; Bower, Michael J.; Hall, Ralph; Griswold, Don Edgar; Underwood, David C., 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors.
  6. Adams,Jerry L.; Bower,Michael J.; Boehm,Jeffrey C.; Griswold,Don Edgar; Underwood,David C., 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors.
  7. Adams,Jerry L.; Bower,Michael J.; Hall,Ralph; Griswold,Don Edgar; Underwood,David C., 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors.
  8. Jerry L. Adams ; Jeffrey C. Boehm, 4,5-disubstituted imidazole compounds.
  9. Richard M Weier ; Paul W Collins ; Michael A Stealey ; Thomas E Barta ; Renee M Huff, 4,5-substituted imidazolyl compounds for the treatment of inflammation.
  10. Sisko Joseph, 4-aryl-5-pyrimidine imiazole substituted compounds.
  11. Callahan, James F.; Boehm, Jeffrey C.; Cooper, Anthony William James; Livia, Stefano; Bamborough, Paul; Nevins, Neysa; Wan, Zehong; Norton, Beth A.; Lin, Xichen, 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase.
  12. Jerry Leroy Adams ; Timothy Francis Gallagher ; Irennegbe Kelly Osifo ; Jeffrey Charles Boehm, Amino substituted pyrimidine containing compounds.
  13. Hegde Vinod R. (Rockaway NJ) Patel Mahesh G. (Verona NJ) Horan Ann C. (Summit NJ) Gunnarsson Ingrid-Agneta (Hackettstown NJ), Antifungal compound and AFC complex produced from actinomadura SCC 1838.
  14. Adams, Jerry L.; Lee, Dennis; Long, Scott A., Aryloxy substituted pyrimidine imidazole compounds.
  15. Weier Richard M. (240 Hickory Ct. Lake Bluff IL 60044) Collins Paul W. (1557 Hawthorne Pl. Deerfield IL 60015) Stealey Michael A. (502 Juniper Pkwy. Libertyville IL 60048) Barta Thomas E. (1133 Maple, Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation.
  16. Adams Jerry L. (Wayne PA) Sheldrake Peter W. (Tunbridge Wells GB2) Gallagher Timothy F. (Harleysville PA) Garigipati Ravishanker (Wayne PA), Compounds.
  17. Adams Jerry Leroy ; Gallagher Timothy Francis ; Lee John C. ; White John Richard, Compounds.
  18. Adams, Jerry Leroy; Gallagher, Timothy Francis; Lee, John C.; White, John Richard, Compounds.
  19. Callahan, James F.; Boehm, Jeffrey C.; Cooper, Anthony William James; Livia, Stefano; Bamborough, Paul; Nevins, Neysa; Wan, Zehong; Norton, Beth A.; Lin, Xichen, Compounds.
  20. Gallagher, Timothy Francis; Boehm, Jeffrey Charles; Adams, Jerry Leroy, Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses.
  21. Lloyd Lester J. ; Lloyd Peter M. ; Rubsamen Reid M. ; Schuster Jeffrey A., Creating an aerosolized formulation of insulin.
  22. Jerry L. Adams ; Ravi Garigipati, Cycloalkenyl substituted compounds.
  23. Adams Jerry L. ; Garigipati Ravi S., Cycloalkyl substituted imidazoles.
  24. Adams Jerry L. ; Garigipati Ravi S. ; Sorenson Margaret E., Cycloalkyl substituted imidazoles.
  25. Adams Jerry Leroy ; Boehm Jeffrey Charles ; Garigipati Ravi Shanker ; Sorenson Margaret, Cycloalkyl substituted imidazoles.
  26. Toyokuni,Tatsushi; Satyamurthy,Nagichettiar; Herschman,Harvey R.; Phelps,Michael E.; Barrio,Jorge R., Cyclooxygenase-2 selective agents useful as imaging probes and related methods.
  27. Lloyd Lester J. ; Lloyd Peter M. ; Rubsamen Reid M. ; Schuster Jeffrey A., Device and method of creating aerosolized mist of respiratory drug.
  28. Lloyd Lester J. ; Lloyd Peter M. ; Rubsamen Reid M. ; Schuster Jeffrey A., Device for aerosolized delivery of peptide drugs.
  29. Lloyd Lester J. ; Lloyd Peter M. ; Rubsamen Reid M. ; Schuster Jeffrey A., Device for aerosolizing narcotics.
  30. Talley, John J.; Sikorski, James A.; Graneto, Matthew J.; Carter, Jeffery S.; Norman, Bryan H.; Devadas, Balekudru; Lu, Hwang-Fun, Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors.
  31. Talley, John J; Sikorski, James A; Graneto, Matthew J; Carter, Jeffrey S; Norman, Bryan H; Devadas, Balekudru; Lu, Hwang-Fun, Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors.
  32. Meanwell Nicholas A. (East Hampton CT), Imidazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith.
  33. Adams Jerry Leroy ; Gallagher Timothy Francis ; Sisko Joseph ; Peng Zhi Qiang ; Osifo Irennegbe Kelly ; Boehm Jeffrey Charles, Imidazole compounds and compositions.
  34. Adams Jerry Leroy (Wayne PA) Gallagher Timothy Francis (Harleysville PA) Sisko Joseph (Hatfield PA) Peng Zhi-Qiang (King of Prussia PA) Osifo Irennegbe Kelly (Eagleville PA) Boehm Jeffrey Charles (Ki, Imidazole compounds, compositions and use.
  35. Adams Jerry L. (SmithKline Beecham Corporation Corporate Intellectual Property UW-2220 P.O. Box 1539 King of Prussia PA 19406-0939) Boehm Jeffrey C. (SmithKline Beecham Corporation Corporate Intellec, Imidazole compounds, use and process of making.
  36. Adams Jerry Leroy (Wayne PA) Gallagher Timothy Francis (Harleysville PA) Lee John C. (Radnor PA) White John Richard (Coatesville PA), Imidazole derivatives and their use as cytokine inhibitors.
  37. Gregory,Susan A.; Isakson,Peter C.; Anderson,Gary, Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor.
  38. Gonda Igor ; Rubsamen Reid M. ; Farr Stephen J., Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume.
  39. Gonda Igor ; Rubsamen Reid M. ; Farr Stephen J., Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume.
  40. Gonda Igor ; Rubsamen Reid M. ; Farr Stephen J., Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume.
  41. Gonda, Igor; Rubsamen, Reid M.; Farr, Stephen J., Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume.
  42. Gonda,Igor; Rubsamen,Reid M.; Farr,Stephen J., Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume.
  43. Gonda Igor ; Rubsamen Reid M., Insulin delivery enhanced by coached breathing.
  44. Gonda Igor ; Rubsamen Reid M., Insulin delivery enhanced by coached breathing.
  45. Gonda, Igor; Rubsamen, Reid M., Insulin delivery enhanced by coached breathing.
  46. Igor Gonda ; Reid M. Rubsamen, Insulin delivery enhanced by coached breathing.
  47. Rubsamen Reid M., Intrapulmonary delivery of hematopoietic drug.
  48. Rubsamen Reid M. ; Lloyd Lester John, Intrapulmonary delivery of narcotics.
  49. Rubsamen Reid M. ; Lloyd Lester John ; Johansson Eric T., Lockout device for controlled release of drug from patient-activated dispenser.
  50. Rubsamen Reid M. ; Lloyd Lester John, Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease.
  51. Gonda Igor ; Rubsamen Reid M., Method of delivering insulin lispro.
  52. Gonda Igor ; Rubsamen Reid M., Method of maintaining a diabetic patient's blood glucose level in a desired range.
  53. Lloyd Lester J. ; Lloyd Peter M. ; Rubsamen Reid M. ; Schuster Jeffrey A., Method of reproducibly effecting a patient's glucose level.
  54. Gonda Igor ; Rubsamen Reid M. ; Farr Stephen J., Method of treating a diabetic patient by aerosolized administration of insulin lispro.
  55. Gonda,Igor; Rubsamen,Reid M.; Farr,Stephen J., Method of treating diabetes mellitus in a patient.
  56. Gonda Igor ; Rubsamen Reid M. ; Farr Stephen J., Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin.
  57. Gonda Igor ; Rubsamen Reid M. ; Farr Stephen J., Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin.
  58. Gonda,Igor; Rubsamen,Reid M.; Farr,Stephen J., Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin.
  59. Gonda,Igor; Rubsamen,Reid M.; Farr,Stephen J., Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin.
  60. Igor Gonda ; Reid M Rubsamen ; Stephen J. Farr, Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin.
  61. Igor Gonda ; Reid M. Rubsamen ; Stephen J. Farr, Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin.
  62. Igor Gonda ; Reid M. Rubsamen ; Stephen J. Farr, Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin.
  63. Albert Duranton FR; Olivier De Lacharriere FR, Modulating body/cranial hair growth.
  64. Adams Jerry Leroy ; Gallagher Timothy Francis ; Sisko Joseph ; Osifo Irennegbe Kelly ; Boehm Jeffrey Charles, Process for making pyridyl and pyrimidine substituted imidazole compounds.
  65. Sheldrake Peter William (Kent GB2) Gallagher Timothy Francis (Harleysville PA) Sisko Joseph (Lansdale PA), Process for preparing pyrimidyl imidazoles.
  66. Briskin Jacqueline E. ; Gupta Pramod K. ; Loyd Claud ; Kohler Robert W. ; Semla Susan J., Process for the preparation of fine particle pharmaceutical formulations.
  67. Adams Jerry L. ; Boehm Jeffrey C., Process of preparing imidazole compounds.
  68. Adams Jerry Leroy ; Gallagher Timothy Francis ; Sisko Joseph ; Peng Zhi Qiang ; Osifo Irennegbe Kelly ; Boehm Jeffrey Charles, Process of preparing imidazole compounds.
  69. Carter, Jeffery S., Prodrugs of COX-2 inhibitors.
  70. Adams, Jerry L.; Gallagher, Timothy; Osifo, Irennegbe Kelly, Pyrazole and pyrazoline substituted compounds.
  71. John J Talley ; James A Sikorski ; Matthew J Graneto ; Jeffrey S Carter ; Bryan H Norman ; Balekudru Devadas ; Hwang-Fun Lu, Pyrazole substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors.
  72. Lee, Wen-Cherng; Carter, Mary Beth; Sun, Lihong; Lyne, Paul; Chuaqui, Claudio; Zheng, Zhongli; Singh, Juswinder; Boriack-Sjodin, Paula, Pyrazolopyridines and methods of making and using the same.
  73. Adams, Jerry L.; Hall, Ralph F.; Boehm, Jeffrey C., Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines.
  74. Adams, Jerry L.; Hall, Ralph F.; Boehm, Jeffrey C., Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines.
  75. Adams Jerry Leroy ; Gallagher Timothy Francis ; Lee John C. ; White John Richard, Pyrimidinyl imidazoles.
  76. Adams Jerry L. ; Boehm Jeffrey C., Substituted imidazole compounds.
  77. Adams Jerry L. ; Boehm Jeffrey C. ; Gallagher Timothy Francis, Substituted imidazole compounds.
  78. Adams Jerry L. ; Boehm Jeffrey C. ; Lee Dennis, Substituted imidazole compounds.
  79. Adams Jerry L. ; Boehm Jeffrey C. ; Lee Dennis, Substituted imidazole compounds.
  80. Adams, Jerry L., Substituted imidazole compounds.
  81. Adams, Jerry L.; Boehm, Jeffrey C.; Gallagher, Timothy Francis, Substituted imidazole compounds.
  82. Adams, Jerry L; Hall, Ralph F, Substituted imidazole compounds.
  83. Adams,Jerry L.; Hall,Ralph F., Substituted imidazole compounds.
  84. Jerry L. Adams ; Ralph F. Hall, Substituted imidazole compounds.
  85. Adams, Jerry L.; Dillon, Susan B.; Griego, Sandra D.; Lee, Dennis, Substituted imidazoles having anti-cancer and cytokine inhibitory activity.
  86. Talley,John J.; Sikorski,James A.; Devadas,Balekudru; Graneto,Matthew J.; Carter,Jeffery S.; Norman,Bryan H.; Rogers, legal representative,Kathy L.; Lu,Hwang Fun; Brown,David L.; Rogers, deceased,Rol, Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors.
  87. Adams,Jerry L.; Lee,Dennis, Substituted triazole compounds.
  88. Sisko Joseph, Synthesis for 4-aryl-5-pyrimidine imidazole substituted compounds.
  89. Sisko Joseph, Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives.
  90. Sisko Joseph, Synthesis of intermediate compounds for 4-adyl-5-pyrimidine imidazole substituted derivatives.
  91. Talley, John J.; Sikorski, James A.; Graneto, Matthew J.; Carter, Jeffery S.; Norman, Bryan H.; Devadas, Balekudru; Lu, Hwang-Fun, Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors.
  92. Talley, John J; Sikorski, James A; Graneto, Matthew J; Carter, Jeffrey S; Norman, Bryan H; Devadas, Balekudru; Hwang-Fun, Lu, Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors.
  93. Feuerstein Giora Z., Treatment for CNS injuries.
  94. Gonda Igor ; Rubsamen Reid M. ; Farr Stephen J., Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로